Clinical trial
The Efficacy of Hyaluronidase as an Adjuvant to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block in Percutaneous Nephrolithotomy. Randomized Double-blind Controlled Study
NCT07102771 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Hyaluronidase as an Adjuvant to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block in Percutaneous Nephrolithotomy. Randomized Double-blind Controlled Study
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2025
- Completion date
- December 30, 2025
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
erector spinae plane block, nephrolithotomy, hyaluronidase